The Biomedical Advanced Research and Development Authority (BARDA) launches the Patch Forward Prize, a $50 million prize pool competition aimed at advancing microneedle patch-based RNA vaccines for COVID-19, seasonal influenza, and pandemic influenza. This opportunity is designed to propel patch-based vaccines toward Phase I clinical trials and is open to domestic and international legal entities.

The concept stage submission deadline is due October 3rd. Visit the FAQ page for more information or begin your application visit the competition website.